Can we contain the COVID-19 outbreak with the same measures as for SARS?
The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of c...
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2020-05, Vol.20 (5), p.e102-e107 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e107 |
|---|---|
| container_issue | 5 |
| container_start_page | e102 |
| container_title | The Lancet infectious diseases |
| container_volume | 20 |
| creator | Wilder-Smith, Annelies Chiew, Calvin J Lee, Vernon J |
| description | The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine. By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82 000 confirmed cases of COVID-19 have been reported with more than 2800 deaths. Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19. COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. Exportations to other countries need not result in rapid large-scale outbreaks, if countries have the political will to rapidly implement countermeasures. |
| doi_str_mv | 10.1016/S1473-3099(20)30129-8 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7102636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A622368164</galeid><els_id>S1473309920301298</els_id><sourcerecordid>A622368164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c606t-80f26860f04fc6b78e94db9313978d91c291f3afada28b92dc6aa668ed0009da3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EomXhI4AsIaFyCPhfHPvSarUFWqlSJRa4Wo4z2XVJ4mInLf32eDelAi6cbHl-88bzHkIvKXlHCZXv11RUvOBE6yNG3nJCmS7UI3SYn0UhRFk93t9n5AA9S-mKEFpRIp6iA85oJqQ6RGcrO-BbwC4Mo_UDHreAV5ffzk8LqnGYxjqC_Y5v_bjdl5LtAfdg0xQhYZtwGyJeLz-vT56jJ63tEry4Pxfo68cPX1ZnxcXlp_PV8qJwksixUKRlUknSEtE6WVcKtGhqzSnXlWo0dUzTltvWNpapWrPGSWulVNAQQnRj-QIdz7rXU91D42AYo-3MdfS9jXcmWG_-rgx-azbhxuTVmeQyCxzdC8TwY4I0mt4nB11nBwhTMoxXZUlKmb1boNf_oFdhikNezzDBZEmFoCxTb2ZqYzswfthZCT_HjZ1SMmYpGeNSUSkyWM6giyGlCO3Drykxu1DNPlSzS8wwYvahGpX7Xv258kPX7xQzcDIDkI2_8RBNch4GB42P4EbTBP-fEb8AWTKubQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2426514412</pqid></control><display><type>article</type><title>Can we contain the COVID-19 outbreak with the same measures as for SARS?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Wilder-Smith, Annelies ; Chiew, Calvin J ; Lee, Vernon J</creator><creatorcontrib>Wilder-Smith, Annelies ; Chiew, Calvin J ; Lee, Vernon J</creatorcontrib><description>The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine. By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82 000 confirmed cases of COVID-19 have been reported with more than 2800 deaths. Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19. COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. Exportations to other countries need not result in rapid large-scale outbreaks, if countries have the political will to rapidly implement countermeasures.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(20)30129-8</identifier><identifier>PMID: 32145768</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Community ; Contact tracing ; Coronavirus Infections - epidemiology ; Coronaviruses ; COVID-19 ; Disease Outbreaks ; Disease transmission ; Enforcement ; Epidemics ; Fatalities ; Fever ; Health aspects ; Humans ; Hygiene ; Infectious diseases ; Medical colleges ; Outbreaks ; Pandemics ; Patients ; Personal View ; Pneumonia, Viral - epidemiology ; Public Health ; Quarantine ; Severe acute respiratory syndrome ; Severe Acute Respiratory Syndrome - epidemiology ; Severe acute respiratory syndrome coronavirus 2 ; Social distancing ; Viral diseases ; Viruses ; World health</subject><ispartof>The Lancet infectious diseases, 2020-05, Vol.20 (5), p.e102-e107</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><rights>2020. Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c606t-80f26860f04fc6b78e94db9313978d91c291f3afada28b92dc6aa668ed0009da3</citedby><cites>FETCH-LOGICAL-c606t-80f26860f04fc6b78e94db9313978d91c291f3afada28b92dc6aa668ed0009da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2426514412?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32145768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilder-Smith, Annelies</creatorcontrib><creatorcontrib>Chiew, Calvin J</creatorcontrib><creatorcontrib>Lee, Vernon J</creatorcontrib><title>Can we contain the COVID-19 outbreak with the same measures as for SARS?</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine. By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82 000 confirmed cases of COVID-19 have been reported with more than 2800 deaths. Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19. COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. Exportations to other countries need not result in rapid large-scale outbreaks, if countries have the political will to rapidly implement countermeasures.</description><subject>Community</subject><subject>Contact tracing</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease Outbreaks</subject><subject>Disease transmission</subject><subject>Enforcement</subject><subject>Epidemics</subject><subject>Fatalities</subject><subject>Fever</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hygiene</subject><subject>Infectious diseases</subject><subject>Medical colleges</subject><subject>Outbreaks</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Personal View</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Public Health</subject><subject>Quarantine</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe Acute Respiratory Syndrome - epidemiology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Social distancing</subject><subject>Viral diseases</subject><subject>Viruses</subject><subject>World health</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkU9v1DAQxS0EomXhI4AsIaFyCPhfHPvSarUFWqlSJRa4Wo4z2XVJ4mInLf32eDelAi6cbHl-88bzHkIvKXlHCZXv11RUvOBE6yNG3nJCmS7UI3SYn0UhRFk93t9n5AA9S-mKEFpRIp6iA85oJqQ6RGcrO-BbwC4Mo_UDHreAV5ffzk8LqnGYxjqC_Y5v_bjdl5LtAfdg0xQhYZtwGyJeLz-vT56jJ63tEry4Pxfo68cPX1ZnxcXlp_PV8qJwksixUKRlUknSEtE6WVcKtGhqzSnXlWo0dUzTltvWNpapWrPGSWulVNAQQnRj-QIdz7rXU91D42AYo-3MdfS9jXcmWG_-rgx-azbhxuTVmeQyCxzdC8TwY4I0mt4nB11nBwhTMoxXZUlKmb1boNf_oFdhikNezzDBZEmFoCxTb2ZqYzswfthZCT_HjZ1SMmYpGeNSUSkyWM6giyGlCO3Drykxu1DNPlSzS8wwYvahGpX7Xv258kPX7xQzcDIDkI2_8RBNch4GB42P4EbTBP-fEb8AWTKubQ</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Wilder-Smith, Annelies</creator><creator>Chiew, Calvin J</creator><creator>Lee, Vernon J</creator><general>Elsevier Ltd</general><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200501</creationdate><title>Can we contain the COVID-19 outbreak with the same measures as for SARS?</title><author>Wilder-Smith, Annelies ; Chiew, Calvin J ; Lee, Vernon J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c606t-80f26860f04fc6b78e94db9313978d91c291f3afada28b92dc6aa668ed0009da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Community</topic><topic>Contact tracing</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease Outbreaks</topic><topic>Disease transmission</topic><topic>Enforcement</topic><topic>Epidemics</topic><topic>Fatalities</topic><topic>Fever</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hygiene</topic><topic>Infectious diseases</topic><topic>Medical colleges</topic><topic>Outbreaks</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Personal View</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Public Health</topic><topic>Quarantine</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe Acute Respiratory Syndrome - epidemiology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Social distancing</topic><topic>Viral diseases</topic><topic>Viruses</topic><topic>World health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilder-Smith, Annelies</creatorcontrib><creatorcontrib>Chiew, Calvin J</creatorcontrib><creatorcontrib>Lee, Vernon J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilder-Smith, Annelies</au><au>Chiew, Calvin J</au><au>Lee, Vernon J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can we contain the COVID-19 outbreak with the same measures as for SARS?</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>20</volume><issue>5</issue><spage>e102</spage><epage>e107</epage><pages>e102-e107</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><abstract>The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. SARS was eventually contained by means of syndromic surveillance, prompt isolation of patients, strict enforcement of quarantine of all contacts, and in some areas top-down enforcement of community quarantine. By interrupting all human-to-human transmission, SARS was effectively eradicated. By contrast, by Feb 28, 2020, within a matter of 2 months since the beginning of the outbreak of coronavirus disease 2019 (COVID-19), more than 82 000 confirmed cases of COVID-19 have been reported with more than 2800 deaths. Although there are striking similarities between SARS and COVID-19, the differences in the virus characteristics will ultimately determine whether the same measures for SARS will also be successful for COVID-19. COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. Exportations to other countries need not result in rapid large-scale outbreaks, if countries have the political will to rapidly implement countermeasures.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>32145768</pmid><doi>10.1016/S1473-3099(20)30129-8</doi><tpages>e102</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2020-05, Vol.20 (5), p.e102-e107 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7102636 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Community Contact tracing Coronavirus Infections - epidemiology Coronaviruses COVID-19 Disease Outbreaks Disease transmission Enforcement Epidemics Fatalities Fever Health aspects Humans Hygiene Infectious diseases Medical colleges Outbreaks Pandemics Patients Personal View Pneumonia, Viral - epidemiology Public Health Quarantine Severe acute respiratory syndrome Severe Acute Respiratory Syndrome - epidemiology Severe acute respiratory syndrome coronavirus 2 Social distancing Viral diseases Viruses World health |
| title | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A38%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20we%20contain%20the%20COVID-19%20outbreak%20with%20the%20same%20measures%20as%20for%20SARS?&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Wilder-Smith,%20Annelies&rft.date=2020-05-01&rft.volume=20&rft.issue=5&rft.spage=e102&rft.epage=e107&rft.pages=e102-e107&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(20)30129-8&rft_dat=%3Cgale_pubme%3EA622368164%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2426514412&rft_id=info:pmid/32145768&rft_galeid=A622368164&rft_els_id=S1473309920301298&rfr_iscdi=true |